Clinical Trial Update: Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate fenretinide in men with biochemically recurrent, hormone-naïve prostate cancer; the study is completed and results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Fenretinide (fenretinide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Prostate, Recurrent Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-03-06